CLOV affiliate plans sale of 10,192 shares

An affiliate of ticker CLOV plans to sell 10,192 shares of Class A Common Stock through Morgan Stanley Smith Barney LLC on Nasdaq around July 15, 2026, with an aggregate market value of 47,698.56.

Accepted by SEC EDGAR 07/15/2026 - 05:41 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

An affiliate of ticker CLOV plans to sell 10,192 shares of Class A Common Stock through Morgan Stanley Smith Barney LLC on Nasdaq around July 15, 2026, with an aggregate market value of 47,698.56.

Total Class A shares outstanding are 430,969,398; this is a baseline figure, not the amount being sold. Over the past three months, 4,681 shares were sold for 21,579.41 under a 10b5-1 plan.

Key Figures

Shares to be sold: 10,192 shares Aggregate market value of planned sale: 47,698.56 Shares outstanding: 430,969,398 shares +3 more

6 metrics

Shares to be sold 10,192 shares Planned sale of Class A Common Stock around 07/15/2026

Aggregate market value of planned sale 47,698.56 Value of 10,192 Class A shares to be sold

Shares outstanding 430,969,398 shares Class A Common Stock outstanding for CLOV

Prior 3-month shares sold 4,681 shares 10b5-1 plan sale on 06/15/2026

Value of prior 3-month sale 21,579.41 Aggregate amount for 4,681-share 10b5-1 sale

Planned sale date 07/15/2026 Approximate date for selling 10,192 shares

Key Terms

Form 144, 10b5-1 Plan, Restricted Stock Units, Class A Common Stock

4 terms

Form 144 regulatory

"144: Securities Information Class A Common Stock | Morgan Stanley"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 Plan regulatory

"10b5-1 Plan Sales for Karen Soares 1209 Orange Street"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Restricted Stock Units financial

"07/15/2026 | Restricted Stock Units | Issuer | | | 10192"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"Class A Common Stock | Morgan Stanley Smith Barney LLC"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CLOV Form 144 notice describe?

It describes a planned sale of 10,192 shares of Class A Common Stock by an affiliate of CLOV through Morgan Stanley Smith Barney LLC on Nasdaq, expected around July 15, 2026, with an aggregate market value of 47,698.56.

How many CLOV shares are planned to be sold and at what value?

The affiliate plans to sell 10,192 Class A Common shares, with an aggregate market value listed as 47,698.56. These shares will be sold through Morgan Stanley Smith Barney LLC on Nasdaq around July 15, 2026.

What CLOV share sales occurred in the last three months?

In the last three months, a 10b5-1 plan transaction shows the sale of 4,681 shares of CLOV Class A Common Stock for an aggregate amount of 21,579.41, dated June 15, 2026, for Karen Soares.

How many CLOV Class A shares are outstanding?

The notice lists 430,969,398 Class A Common shares outstanding for CLOV. This figure provides context for the issuer’s total equity base and is separate from the 10,192 shares proposed for sale.

What type of CLOV security is involved and how was it acquired?

The security is CLOV Class A Common Stock, linked to Restricted Stock Units from the issuer categorized as Compensation. This indicates the planned sale relates to equity previously granted by the issuer.

On which exchange and through which broker will CLOV shares be sold?

The planned sale of CLOV Class A Common Stock is to occur on the Nasdaq market, using Morgan Stanley Smith Barney LLC as the executing broker, according to the Form 144 details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001999086
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	Karen Soares
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	10192	47698.56	430969398	07/15/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	07/15/2026	Restricted Stock Units	Issuer			10192	07/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Plan Sales for Karen Soares 1209 Orange Street Wilmington DE 19801	Class A Common Stock	06/15/2026	4681	21579.41

144: Remarks and Signature

Remarks	The proposed sales reported represent shares to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The purpose of the proposed sales is to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the reporting person.
Date of Notice	07/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Peter J. Rivas as attorney-in-fact for Karen Soares
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)